
Science Translational Medicine
- Volume 13
- Issue 609
- 01 Sep 2021

ONLINE COVER Minimizing Metastases. This scanning electron micrograph shows metastatic mouse tumor cells (in green) invading the lung parenchyma and stroma, in close contact with nearby capillaries (red). Singhal et al. studied the vascular niche after surgical resection of spontaneously metastasizing primary tumors in mice. Using transcriptomics and proteomics, they identified leucine-rich alpha-2 glycoprotein 1 (LRG1), produced by endothelial cells in response to tumor-induced inflammation, as a prometastatic molecule. Treatment with LRG1-neutralizing antibodies led to decreased metastatic burden and prolonged survival in these mice, suggesting that LRG1 may be a potential target to restrict metastatic tumor growth.[CREDIT: Eye of Science]
- Lina Acevedo Rua
- Marcus Mumme
- et al.
Engineered nasal cartilage for the repair of osteoarthritic knee cartilage defects
- Ulrike B. S. Hedrich
- Stephan Lauxmann
- et al.
4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy
- Michelle F. Griffin
- Mimi R. Borrelli
- et al.
JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models
- Pınar Özden Eser
- Raymond M. Paranal
- et al.
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer
Advertisement
Focus
Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine.
mission & scope


























